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ABSTRACT
Background: The postprandial triglyceride-rich lipoprotein (TRL)
concentration is a recognized independent cardiovascular disease
risk factor. Diet is the natural approach for these postprandial alter-
ations. Dietary polyphenols and long chain n23 polyunsaturated
fatty acids (LCn3s) are associated with a lower cardiovascular dis-
ease risk.
Objective: This randomized controlled study evaluated, in persons
with a high risk of cardiovascular disease, the effects of diets nat-
urally rich in polyphenols and/or marine LCn3s on plasma TRLs
and urinary 8-isoprostane concentrations, a biomarker of oxidative
stress.
Design: According to a 2 3 2 factorial design, 86 overweight/obese
individuals with a large waist circumference and any other compo-
nent of the metabolic syndrome were randomly assigned to an iso-
energetic diet 1) poor in LCn3s and polyphenols, 2) rich in LCn3s,
3) rich in polyphenols, or 4) rich in LCn3s and polyphenols. The
diets were similar in all other components. Before and after the
8-wk intervention, fasting and postmeal TRLs and 8-isoprostane
concentrations in 24-h urine samples were measured.
Results: Dietary adherence was good in all participants. Polyphe-
nols significantly reduced fasting triglyceride concentrations (2-factor
ANOVA) in plasma (P = 0.023) and large very-low-density lipopro-
teins (VLDLs) (P = 0.016) and postprandial triglyceride total area
under the curve in plasma (P = 0.041) and large VLDLs (P = 0.004).
LCn3s reduced postprandial chylomicron cholesterol and VLDL
apolipoprotein B-48. The concentrations of urinary 8-isoprostane
decreased significantly with the polyphenol-rich diets. Lipoprotein
changes induced by the intervention significantly correlated with
changes in 8-isoprostane.
Conclusions: Diets naturally rich in polyphenols positively influ-
ence fasting and postprandial TRLs and reduce oxidative stress.
Marine LCn3s reduce TRLs of exogenous origin. Through their
effects on postprandial lipemia and oxidative stress, polyphenols
may favorably affect cardiovascular disease risk. This trial was
registered at clinicaltrials.gov as NCT00781365. Am J Clin Nutr
2014;99:463–71.
INTRODUCTION
Cardiovascular disease (CVD)4 is the leading cause of mor-
bidity and mortality in industrialized countries (1). In addition to
the established CVD risk factors, other relevant factors include
fasting and postprandial alterations in lipoprotein metabolism,
endothelial dysfunction, oxidative stress, and subclinical in-
flammation (2). In particular, postprandial metabolic abnor-
malities may play an important role considering that, in our
society, people spend most of their time in the absorptive con-
dition (3). Diet is the natural approach for postprandial alter-
ations, and, because of its pleiotropic action, it may modulate
several major and emerging CVD risk factors at the same time,
with favorable and multiplicative effects, as suggested by pro-
spective studies (4, 5). Of the dietary components that might
positively influence the risk of chronic diseases, long-chain n23
PUFAs (LCn3s) and, more recently, polyphenols have attracted
much interest.
Epidemiologic studies have shown an association between
a higher intake of polyphenols and a lower risk of CVD, diabetes
mellitus, cancer, and neurodegenerative disorders (6, 7). Dif-
ferent mechanisms may mediate these putative protective effects,
including changes in lipid metabolism, both at fasting and
postprandially (8, 9). However, the few human intervention
studies conducted have produced conflicting results, with some
studies showing impressive positive effects and others just the
opposite or no effect at all (9). Furthermore, whereas these studies
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explored the effects of polyphenols contained in individual foods
(tea, chocolate, red wine, etc), the effects of diets containing
different natural sources of polyphenols were not investigated.
This is relevant because polyphenols differ in terms of their
metabolic characteristics, such as bioavailability and the activity
of their intermediate metabolites (10). Given the antioxidant
capacity of polyphenols—shown in vitro and in animal studies
(11)—another possible cardioprotective mechanism may relate
to their role in counteracting oxidative stress, which is a key
point in the pathogenesis of CVD.
LCn3s have shown a cardioprotective effect in epidemiologic
studies and clinical trials (12). The effects of dietary LCn3s,
although widely investigated and associated with an overall fa-
vorable lipoprotein profile in terms of CVD risk (13), still need to
be clarified, especially in relation to oxidative stress and post-
prandial lipid metabolism (14, 15). Moreover, in many human
studies, marine LCn3s were given as supplements and not by
increasing the consumption of food naturally rich in LCn3s.
Finally, only a few in vitro (16) and acute (15) studies of the
combined effects of polyphenols and LCn3s and the possible
interactions between these 2 dietary components are available,
which could, respectively, reduce or increase oxidative stress.
Therefore, the aim of this randomized controlled intervention
study was to elucidate in individuals with features of the met-
abolic syndrome, and therefore at high risk of type 2 diabetes and
CVD, the medium-term effects of diets naturally rich in different
sources of polyphenols and/or marine LCn3s on 1) lipid me-
tabolism, focusing on postprandial state, and 2) oxidative stress.
SUBJECTS AND METHODS
Patients
Eighty-six individuals of both sexes, aged 35–70 y, with
a large BMI (in kg/m2; 27–35) and waist circumference (men,
.102 cm; women, .88 cm) were recruited from patients re-
ferred to the obesity outpatient clinic of the Federico II University
Hospital. Health status and medical history were assessed by in-
terviews, clinical examinations, and routine laboratory tests, and
glucose tolerance was evaluated with a 75-g oral-glucose-tolerance
test. In addition to a large BMI and waist circumference, subjects
had to have at least one or more components of the metabolic
syndrome per the Adult Treatment Panel III (17). Exclusion criteria
were as follows: CVD events (myocardial infarction or stroke) in
the past 6 mo, diabetes mellitus, fasting plasma triglycerides $400
mg/dL or cholesterol .270 mg/dL, regular intensive physical ac-
tivity, renal failure (serum creatinine .1.7 mg/dL), liver disease,
anemia, any other chronic disease, or use of drugs able to influence
glucose and lipid metabolism or inflammation. Eight subjects, who
were equally distributed among the 4 experimental groups, were
not evaluated at the end of the intervention because of an
unwillingness to repeat the tests or for job or family reasons
(see Supplemental Figure 1 under “Supplemental data” in the
online issue). The clinical characteristics of the 78 participants
who completed the dietary intervention are shown in Table 1.
The study protocol was approved by the Federico II University
Ethics Committee. All participants gave their written informed
consent to participate in the study.
Study design
According to a 2 3 2 factorial design, participants were
randomly assigned to one of the following nutritional iso-
energetic interventions for 8 wk: 1) control diet, low in LCn3s
and polyphenols; 2) diet rich in LCn3s and low in polyphenols;
3) diet rich in polyphenols and low in LCn3s; or 4) diet rich in
LCn3s and polyphenols. During the 3-wk run-in period, par-
ticipants were stabilized with a diet that reflected their eating
habits. As shown in Table 2, the assigned diets differed only in
LCn3 and polyphenol contents and were similar in all other
characteristics, including macronutrient composition and con-
tent of micronutrients that could possibly affect outcomes, es-
pecially for their antioxidant properties. Dietary composition
was derived from the tables of the Italian National Research
Institute for Food and Nutrition (18), whereas polyphenol con-
tents and the Oxygen Radical Absorbance Capacity index were
calculated according to USDA tables (19). The polyphenol
content in tea, coffee, chocolate, and blueberry jam was
measured directly (20). The main dietary sources of poly-
phenols were decaffeinated green tea, decaffeinated coffee, dark
TABLE 1
Baseline characteristics of the 4 groups of participants in the dietary intervention study1
Control High LCn3s
High
polyphenols
High polyphenols
and high LCn3s
P value
(ANOVA)
Sex (M/F) 8/12 8/11 9/11 8/11
Age (y) 54 6 92 56 6 8 53 6 9 55 6 9 0.645
Body weight (kg) 87 6 10 86 6 12 87 6 11 84 6 12 0.858
BMI (kg/m2) 33 6 3 32 6 4 32 6 3 30 6 3 0.126
Waist circumference (cm) 104 6 7 105 6 10 104 6 9 101 6 8 0.601
Systolic blood pressure (mm Hg) 120 6 7 121 6 12 126 6 16 119 6 9 0.231
Diastolic blood pressure (mm Hg) 76 6 8 74 6 7 76 6 9 73 6 8 0.663
Fasting plasma triglycerides (mg/dL) 120 6 47 138 6 68 120 6 60 125 6 78 0.787
Fasting plasma cholesterol (mg/dL) 194 6 38 191 6 26 194 6 34 193 6 27 0.992
HDL cholesterol (mg/dL) 43 6 10 41 6 11 43 6 9 44 6 14 0.855
LDL cholesterol (mg/dL) 118 6 30 114 6 22 117 6 26 112 6 30 0.874
Fasting plasma glucose (mg/dL) 104 6 12 104 6 12 100 6 9 103 6 11 0.498
Urinary 8-isoprostane (ng/24 h) 1176 6 485 1037 6 475 1433 6 752 1385 6 660 0.169
1LCn3, long-chain n23 PUFA.
2Mean 6 SD (all such values).
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chocolate, blueberry jam, artichokes, onions, spinach, rocket, and
extra-virgin olive oil (see Supplemental Table 1 under “Supple-
mental data” in the online issue). The distribution of different
classes of polyphenols is shown elsewhere (see Supplemental Ta-
ble 2 under “Supplemental data” in the online issue). The main
sources of LCn3s were salmon, dentex, and anchovies (see Sup-
plemental Table 1 under “Supplemental data” in the online issue).
The initial assigned energy intake of the diet was determined based
on the individual’s habitual energy intake evaluated by a 7-d food
record, adjusted for body weight and clinical judgment of the di-
etitians, in order to take care of a possible underreporting, common
in overweight/obese individuals.
To improve dietary adherence, meals and beverages were
provided to the participants for thewhole study period in amounts
sufficient to cover their household consumption. Meals were
prepared in a qualified catering service under the surveillance of
the dietitians. Adherence to diets was evaluated by a 7-d dietary
record at baseline, 4 wk, and 8 wk and was reinforced by the
dietitians through counseling every week and phone calls every
2–3 d. Participants allocated to high-polyphenol diets or high-
LCn3 diets were considered compliant with the treatment if
intakes were $80% of those assigned; participants allocated to
low-polyphenol or low-LCn3 diets were considered compliant if
intakes were not .20% of those assigned. For all other dietary
components, participants were considered compliant if, for each
component, the intake was within 620% of that assigned.
Procedures
At baseline and after the 8-wk intervention, body weight,
height, and waist circumference were measured according to
standardized procedures (21). After a 12-h overnight fast, the
participants consumed a 1000-kcal test meal composed of rice,
butter, parmesan cheese, bresaola, and white bread, with intakes
of olive oil, extra-virgin olive oil, salmon, and decaffeinated
green tea differing in order to obtain a similar composition as the
assigned diet (see Supplemental Table 3 under “Supplemental
data” in the online issue). Before and 2, 4, and 6 h after the meal,
blood samples were collected for the measurement of plasma
concentrations of cholesterol and triglycerides and triglyceride-
rich lipoproteins (TRLs) (chylomicrons and large VLDLs), and
apolipoprotein B-48 (apo B-48) in large VLDLs. In addition,
24-h urine samples were collected on the day after the test meal,
to measure 8-isoprostane concentrations, after adequately training
the study participants on proper collection and storage procedures.
Laboratory methods
Chylomicrons (Svedberg flotation unit .400) and large
VLDLs (Svedberg flotation unit 60–400) were isolated from
plasma by discontinuous density-gradient ultracentrifugation, as
previously described (22). HDLs were isolated from plasma by
using the phosphotungstic acid/magnesium chloride precipitation
method. LDL cholesterol was calculated by using the Friedewald
formula. Cholesterol, triglyceride, and glucose concentrations
were assayed by enzymatic methods (Roche Molecular Bio-
chemicals) on a Cobas Mira autoanalyser (ABX Diagnostics).
Concentrations of apo B-48 were analyzed in large VLDLs by
ELISA (Shibayagi Co Ltd), automated on a Triturus ELISA
autoanalyzer (Grifols Italia S.p.A).
For isoprostane analysis, after collection, 10-mL urine samples
were centrifuged for 5 min (3000 rpm, at 48C). After removal of
the sediment, they were fractionated into 500-mL aliquots with
the addition of 0.005% butylated hydroxytoluene in ethanol and
stored at 2808C. Immediately before the assay, one aliquot was
thawed in ice, centrifuged, and diluted 10 times. Concentrations
of 8-isoprostane were measured in triplicate with a Cayman
8-isoprostane enzyme immunoassay kit, performed manually,
and read through with DiaSorin EtiStar Spectrophotometry.
Concentrations are expressed as ng isoprostanes released in 24
h. The interassay CV was 14.3%, and the intraassay CV was
8.2%. All evaluations were performed before and after the 8-wk
intervention by personnel who were blind to the assignment.
Statistical analysis
To detect a 30% difference between treatments in the total
AUCs of triglyceride concentrations in the chylomicron and
VLDL fractions after a fat-rich meal, with an 80% power at a 5%
significance level, 80 patients had to be studied. This degree of
change after treatment is clinically based, corresponding to the
differences observed between patients with type 2 diabetes and
healthy control subjects in a previous study (22). The random
allocation to the intervention—stratified for sex, age, BMI, and
plasma triglycerides—was performed by using the minimization
method with MINIM software (www.users.york.ac.uk).
The data are expressed as means6 SDs unless otherwise stated.
Variables not normally distributed were analyzed after logarithmic
transformation. Postprandial total AUCs and incremental AUCs
were calculated by using the trapezoidal method. Data were
analyzed by intention to treat for all subjects with completed
outcomes. An analysis for protocol would yield the same results
because all participants were compliant with treatment. Differ-
ences between the 4 groups at baseline were tested by 1-factor
ANOVA and post hoc analysis with Bonferroni correction for
multiple comparisons. The effects of dietary polyphenols, di-
etary LCn3s, and the interaction between polyphenols and
LCn3s were evaluated by 2-factor ANOVA of absolute values at
8 wk adjusted for baseline values as covariate. The effects in
each intervention group were compared with the control group
by ANOVA and a least-significant-difference post hoc analysis,
when a significant interaction effect was detected by 2-factor
ANOVA. Bivariate associations were assessed by Pearson’s
correlation. Statistical analysis was performed according to
standard methods by using the SPSS statistics version 15.0
(SPSS/PC).
RESULTS
Compliance with dietary intervention
The composition of the diets strictly reflected the dietary
composition assigned per protocol in all groups (Table 2). As
expected, the diets were significantly different in polyphenol and
LCn3 contents. The absolute contents of n23 PUFAs were 1.40 6
0.29, 4.086 0.52, 1.356 0.15, and 3.946 0.76 g/d in the control,
high-LCn3, high-polyphenol, and high-polyphenol and high-LCn3
groups, respectively. The Oxygen Radical Absorbance Capacity
indexes were 6415 6 1181, 6530 6 723, 24,985 6 2665, and
23,159 6 4621 Trolox equivalents in the same 4 groups, re-
spectively. No differences in macronutrients, fiber, and vitamin
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contents were observed between the 4 dietary groups. All sub-
jects were within the ranges of intakes defined for good com-
pliance for each dietary component.
Baseline data
At baseline, the 4 groups were comparable in age, body
weight, BMI, waist circumference, and blood pressure (Table 1).
Fasting plasma concentrations of triglycerides, total cholesterol,
HDL cholesterol, LDL cholesterol, and glucose were not sig-
nificantly different between the groups.
Anthropometric measures
Body weight was relatively stable during the intervention, with
small decreases at 8 wk (20.116 0.67,21.146 1.30,20.576
0.80, and 20.32 6 0.64 kg in the control, high-LCn3, high-
polyphenols, and high-polyphenols and high-LCn3 groups, re-
spectively), which were statistically significant in the group
assigned to LCn3s (P = 0.041). Waist circumference did not
change significantly during the intervention (20.8 6 1.4, 21.1
6 1.5, 20.6 6 1.5, and 21.2 6 1.6 cm in the same 4 groups,
respectively).
Fasting lipids and lipoproteins
The 8-wk interventions with polyphenols, LCn3s, or their
combination, appeared to decrease fasting plasma triglycerides
compared with the control diet (Table 3). By 2-factor ANOVA,
only the effect of polyphenols was statistically significant (P =
0.023); no significant effects for LCn3s or their interaction were
found. Fasting total and LDL-cholesterol concentrations were
not significantly affected by the dietary interventions. Poly-
phenols significantly decreased fasting concentrations of tri-
glyceride and cholesterol in large VLDL and HDL fractions; no
significant effects for LCn3s or their interaction were found.
Postprandial lipids and lipoproteins
The absolute changes after the intervention (8 wk minus
baseline) in postprandial total AUC for lipids and apo B-48 are
shown in Figure 1. The total AUC for plasma triglyceride after
the test meal appeared to decrease in the high-polyphenols,
high-LCn3, and high-polyphenols and high-LCn3 groups. By
2-factor ANOVA, only the effect of polyphenols was statistically
significant (P = 0.041); no significant effects for LCn3 or
their interaction were found. Plasma total cholesterol AUC did
not change significantly with the experimental diets (data not
shown). Chylomicron triglyceride and cholesterol total AUC
appeared to decrease in the LCn3 group, but not significantly so
by 2-factor ANOVA. Total AUCs for large VLDL triglycerides
and cholesterol decreased in the high-polyphenols groups. By
2-factor ANOVA the effect of polyphenols was statistically
significant (P = 0.004 and P = 0.013 for triglycerides and cho-
lesterol, respectively); no significant effects for LCn3s or their
interaction were found. Total AUCs for large VLDL apo B-48
decreased significantly in the high-LCn3 group and the high-
polyphenols group (P, 0.05 for both compared with the control
diet), and the interaction was significant (P = 0.023). The ab-
solute changes after the intervention (8 wk minus baseline) in
postprandial incremental AUCs for lipids and apo B-48 are
shown in Table 4. A decrease in chylomicron cholesterol in-
cremental AUCs was observed in the LCn3 group (P , 0.05
compared with the control diet) in the presence of a significant
negative interaction between LCn3 and polyphenols (P = 0.047,
2-factor ANOVA).
Urinary 8-isoprostane
At baseline, urinary 8-isoprostane concentrations were similar
in the 4 groups (Table 1). The concentrations of 8-isoprostane
decreased in the high-polyphenols groups (Figure 2). By 2-factor
ANOVA, the effect of polyphenols was statistically significant
(P = 0.012); no significant effects for LCn3s or the interaction of
polyphenols with LCn3s were found.
Relation between dietary effects on lipoproteins and
isoprostanes
Dietary effects on urinary 8-isoprostane correlated signifi-
cantly with changes in fasting and postprandial plasma lipo-
proteins, as shown elsewhere for total AUCs for triglycerides and
cholesterol in large VLDLs (see Supplemental Figure 2 under
“Supplemental data” in the online issue). The strength of these
associations was mainly based on the changes observed in the
polyphenol-rich groups.
TABLE 3
Absolute changes after the intervention (8 wk minus baseline) in fasting plasma lipid concentrations1
P2
Control
(n = 20)
High LCn3s
(n = 19)
High
polyphenols
(n = 20)
High
polyphenols and
high LCn3s
(n = 19)
LCn3
effect
Polyphenol
effect
Polyphenol-
LCn3
interaction
Plasma triglycerides (mg/dL) 19 6 49 214 6 56 218 6 31 215 6 40 0.261 0.023 0.095
Plasma total cholesterol (mg/dL) 22 6 23 28 6 21 29 6 21 21 6 24 0.836 0.859 0.175
Large VLDL triglycerides (mg/dL) 7.2 6 32.0 29.4 6 38.2 214.8 6 27.0 211.9 6 26.0 0.872 0.016 0.210
Large VLDL cholesterol (mg/dL) 1.61 6 6.34 21.90 6 7.40 22.19 6 4.88 21.78 6 4.96 0.821 0.045 0.211
LDL cholesterol (mg/dL) 24.07 6 16.2 22.06 6 14.6 26.50 6 18.4 5.20 6 16.4 0.120 0.088 0.835
HDL triglycerides (mg/dL) 1.35 6 2.76 20.58 6 8.83 24.60 6 6.42 21.42 6 4.02 0.910 0.017 0.229
HDL cholesterol (mg/dL) 0.2 6 3.7 0.4 6 4.1 22.4 6 3.9 23.5 6 5.7 0.503 0.005 0.675
1All values are means 6 SDs. LCn3, long-chain n23 PUFA.
2Two-factor ANOVA of absolute values at 8 wk adjusted for baseline values as covariate. P , 0.05 indicates a significant difference.
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DISCUSSION
This was the first randomized controlled trial with an adequate
sample size that investigated medium-term dietary effects of diets
naturally rich in polyphenols and/or LCn3s in individuals at high
risk of type 2 diabetes and CVD. The results indicate that 1) diets
rich in polyphenols of different sources significantly reduce
TABLE 4
Absolute changes after the intervention (8 wk minus baseline) in postprandial incremental AUCs of plasma and lipoprotein triglycerides, cholesterol,
and apo B-481
P2
Control
(n = 20)
High LCn3s
(n = 19)
High
polyphenols
(n = 20)
High
polyphenols and
high LCn3s
(n = 19)
LCn3
effect
Polyphenol
effect
Polyphenol-
LCn3
interaction
Plasma triglyceride (mg/dL $ 6 h) 52 6 294 269 6 275 247 6 236 240 6 149 0.310 0.526 0.252
Plasma total cholesterol (mg/dL $ 6 h) 216 6 42 22 6 72 14 6 58 210 6 52 0.816 0.476 0.187
Chylomicron triglycerides (mg/dL $ 6 h) 54 6 173 253 6 220 23.4 6 194 21.7 6 74 0.189 0.939 0.174
Chylomicron cholesterol (mg/dL $ 6 h) 1.4 6 6.8 22.7 6 7.5* 21.8 6 5.7 20.4 6 2.8 0.351 0.742 0.047
Large VLDL triglycerides (mg/dL $ 6 h) 16 6 130 23.8 6 100 9.8 6 136 242 6 63 0.169 0.384 0.542
Large VLDL cholesterol (mg/dL $ 6 h) 1.0 6 23 22.8 6 21 0.1 6 21 25.8 6 14 0.297 0.676 0.825
Large VLDL apo B-48 (mg/mL $ 6 h) 1.53 6 12 0.27 6 9.83 0.29 6 7.86 0.12 6 4.80 0.741 0.750 0.802
1All values are means 6 SDs. *Significantly different from the control group, P , 0.05 (ANOVA and least-significant-difference post hoc test). apo
B-48, apolipoprotein B-48; LCn3, long-chain n23 PUFA.
2Two-factor ANOVA of absolute values at 8 wk adjusted for baseline values as covariate. P , 0.05 indicates a significant difference.
FIGURE 1. Mean (6SEM) absolute changes after the intervention (8 wk minus baseline) in postprandial tAUCs of whole plasma triglycerides, chylo-
micron triglycerides and cholesterol, and large VLDL triglycerides, cholesterol, and ApoB48 in the 4 experimental groups. *Significantly different from the
control diet, P, 0.05 (ANOVA and least-significant-difference post hoc analysis). xTwo-factor ANOVA of absolute values at 8 wk adjusted for baseline values
as covariate. ApoB48, apolipoprotein B-48; LCn3, long-chain n23 PUFA; tAUC, total AUC.
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plasma triglyceride concentrations, mainly in the large VLDL
fraction, in both the fasting and postprandial states; 2) diets rich
in LCn3s of marine origin reduce postprandial TRLs, mainly
chylomicron remnants; and 3) diets rich in polyphenols reduce
oxidative stress.
Most previous evidence on dietary polyphenols comes from in
vitro and animal studies, wherein selected types of polyphenols
induced triglyceride reductions in plasma, chylomicrons, and
VLDLs and increased HDL-cholesterol concentrations (9). Re-
sults in humans were extremely conflicting; polyphenols showed
only a trend to better outcomes for LDL and HDL cholesterol
and extremely diverging data on triglyceride metabolism (8).
Moreover, very few data were available on the effects of poly-
phenols on postprandial lipids (23). Possible explanations for
these inconsistencies include the use of different single sources of
polyphenols and poor available knowledge of the many factors
that affect the bioavailability of dietary polyphenols in humans
(10). Our controlled study showed that the reduction in tri-
glyceride mainly concerns postprandial TRLs, which are a rec-
ognized independent CVD risk factor (24).
Different potential sites of action of polyphenols on lipid
metabolism have been proposed, particularly reduced triglyceride
absorption, with consequent lower circulating apolipoprotein
B/TRLs and, eventually, remnant lipoproteins (9). Other possible
mechanisms include increased energy expenditure, reduced li-
pogenesis, reduced fat mass, reduced inflammation, and reduced
oxidative stress (25). The effects of polyphenols in our study were
notmediated by changes in bodyweight ormodifications in appetite,
as suggested for catechins, and mostly related to the adrenergic
effects of caffeine (26). In fact, body weight was unchanged during
the trial, and the presence of caffeine was negligible because de-
caffeinated coffee and tea were used.
Although extensively investigated, the effects of LCn3s on
lipid metabolism are still controversial, mainly concerning the
use of natural foods and postprandial responses. In the current
trial, marine LCn3s induced a decrease in the lipid content of
postprandial chylomicrons and a significant reduction in chy-
lomicron remnants. These changes in exogenous lipid metabo-
lism, which correspond to a less-atherogenic lipoprotein profile,
are in line with intervention data showing main effects of n23
PUFAs in functional foods (27), or as supplements in patients
with proteinuria (28), on the chylomicron fraction. It is note-
worthy that, in our study, a significant negative interaction be-
tween LCn3s and polyphenols was observed for the changes in
chylomicron remnants, which suggests a possible effect of poly-
phenols in reducing the absorption of LCn3s together with other
dietary lipids.
An unexpected finding of this trial was the reduction in HDL
cholesterol observed in the groups that consumed a polyphenol-
rich diet. HDL triglycerides were also decreased by polyphenols.
The meaning of this reduction in HDL in terms of CVD risk is
unknown, because changes in HDL composition more than pure
cholesterol content seem to affect this risk (29).
Polyphenols are associated with a lower incidence of CVD and
have potent antioxidant activity, as generally observed in vitro.
The current trial showed a reduction in oxidative stress by dietary
polyphenols in humans, as evidenced by thew20% decrease in
urinary 8-isoprostane concentration, which is a reliable bi-
ological marker of oxidation. Even if polyphenols represent the
main antioxidants in the human diet, this recognized antioxidant
activity is mostly based on in vitro evidence, whereas data in
vivo are few and conflicting (30). In the current trial, the re-
lations observed between the dietary effects on TRLs and
8-isoprostane suggest that improvement of fasting and, espe-
cially, postprandial lipoprotein metabolism may reduce oxida-
tive stress. However, an opposite direction for this process
cannot be ruled out, at least with dietary polyphenols, ie, the
reduction in oxidative stress results in an improved lipoprotein
profile. The reduced oxidative stress could influence lipid me-
tabolism, upregulating enzymes involved in hepatic fat oxida-
tion or decreasing nutrient absorption (31).
The results of this trial are relevant because fasting and
postprandial alterations of TRLs are an independent CVD risk
factor (24). There is no recognized treatment of postprandial
dyslipidemia, and current pharmacologic interventions provide
limited benefit for correcting VLDL alterations. In addition, diet
FIGURE 2. Mean (6SEM) absolute changes after the intervention (8 wk minus baseline) in 24-h urinary concentrations of 8-isoprostane in the 4
experimental groups. Two-factor ANOVA of absolute values at 8 wk adjusted for baseline values as covariate. LCn3, long-chain n23 PUFA.
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is the most natural approach for postprandial alterations, besides
providing other multiple beneficial effects. Oxidative stress is one
of the possible mechanisms involved in the pathogenesis of the
major chronic degenerative diseases. The possibility to act fa-
vorably on this mechanism with a diet naturally rich in different
polyphenols is clinically relevant. In fact, an additional strength
of this study was the use of natural foods rich in polyphenols or
LCn3s, included in a feasible and accepted diet, as shown by the
good adherence observed during the intervention. This differs
from most previous data obtained by using supplements or single
foods (9, 23). In addition, for the first time, the effects of the
combination of these 2 dietary approaches were evaluated. Also,
when combined, they showed beneficial, although nonadditive,
effects on lipids, with a trend to a negative interaction for some
variables (chylomicron cholesterol and apo B-48 in large
VLDLs), which deserves more investigation. A further strength
of this study was that the experimental diets were very similar
for all characteristics other than polyphenols and LCn3 con-
tents, including macronutrient and micronutrient compositions,
ie, factors potentially influencing the outcomes of the trial. This
avoided the most common confounding problem in dietary
studies.
A limitation of this study was that the results apply to indi-
viduals with metabolic abnormalities; therefore, it remains un-
known whether they also apply to individuals without metabolic
alterations or those with more advanced stages of metabolic or
CVDs.
In conclusion, this randomized controlled trial provides evi-
dence that diets naturally rich in marine LCn3s may positively
influence TRLs, mainly chylomicron metabolism, with no ad-
ditive effects of polyphenols. For the first time, positive effects on
fasting and postprandial TRLs were shown for diets naturally rich
in polyphenols, which also reduce oxidative stress. These effects
may contribute to explain the favorable associations of dietary
polyphenols with CVD risk.
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